nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyclobenzaprine—HTR2A—alcohol dependence	0.47	1	CbGaD
Cyclobenzaprine—CYP1A2—Citalopram—alcohol dependence	0.0821	0.324	CbGbCtD
Cyclobenzaprine—CYP2D6—Citalopram—alcohol dependence	0.0677	0.267	CbGbCtD
Cyclobenzaprine—CYP3A4—Disulfiram—alcohol dependence	0.0604	0.238	CbGbCtD
Cyclobenzaprine—CYP3A4—Citalopram—alcohol dependence	0.043	0.17	CbGbCtD
Cyclobenzaprine—HTR2A—locus ceruleus—alcohol dependence	0.0046	0.167	CbGeAlD
Cyclobenzaprine—HTR2A—cerebellar cortex—alcohol dependence	0.00375	0.137	CbGeAlD
Cyclobenzaprine—HTR2A—pons—alcohol dependence	0.00265	0.0965	CbGeAlD
Cyclobenzaprine—HTR2A—autonomic nervous system—alcohol dependence	0.00244	0.089	CbGeAlD
Cyclobenzaprine—HTR2A—nerve—alcohol dependence	0.00138	0.0501	CbGeAlD
Cyclobenzaprine—Extrapyramidal disorder—Citalopram—alcohol dependence	0.000905	0.00544	CcSEcCtD
Cyclobenzaprine—Libido decreased—Acamprosate—alcohol dependence	0.000889	0.00535	CcSEcCtD
Cyclobenzaprine—Disorientation—Naltrexone—alcohol dependence	0.000872	0.00525	CcSEcCtD
Cyclobenzaprine—Thirst—Acamprosate—alcohol dependence	0.000867	0.00521	CcSEcCtD
Cyclobenzaprine—Mydriasis—Citalopram—alcohol dependence	0.000854	0.00514	CcSEcCtD
Cyclobenzaprine—Libido decreased—Naltrexone—alcohol dependence	0.000841	0.00506	CcSEcCtD
Cyclobenzaprine—Ageusia—Citalopram—alcohol dependence	0.000841	0.00506	CcSEcCtD
Cyclobenzaprine—Diplopia—Acamprosate—alcohol dependence	0.000825	0.00496	CcSEcCtD
Cyclobenzaprine—Thirst—Naltrexone—alcohol dependence	0.00082	0.00493	CcSEcCtD
Cyclobenzaprine—Disturbance in sexual arousal—Acamprosate—alcohol dependence	0.000818	0.00492	CcSEcCtD
Cyclobenzaprine—Purpura—Naltrexone—alcohol dependence	0.00081	0.00487	CcSEcCtD
Cyclobenzaprine—Acne—Citalopram—alcohol dependence	0.000809	0.00487	CcSEcCtD
Cyclobenzaprine—Psychotic disorder—Acamprosate—alcohol dependence	0.000805	0.00485	CcSEcCtD
Cyclobenzaprine—Face oedema—Acamprosate—alcohol dependence	0.000796	0.00479	CcSEcCtD
Cyclobenzaprine—Disturbance in attention—Citalopram—alcohol dependence	0.000786	0.00473	CcSEcCtD
Cyclobenzaprine—Aggression—Citalopram—alcohol dependence	0.000775	0.00466	CcSEcCtD
Cyclobenzaprine—Disturbance in sexual arousal—Naltrexone—alcohol dependence	0.000774	0.00466	CcSEcCtD
Cyclobenzaprine—Psychotic disorder—Naltrexone—alcohol dependence	0.000762	0.00458	CcSEcCtD
Cyclobenzaprine—Face oedema—Naltrexone—alcohol dependence	0.000753	0.00453	CcSEcCtD
Cyclobenzaprine—Irritability—Naltrexone—alcohol dependence	0.000745	0.00448	CcSEcCtD
Cyclobenzaprine—Thinking abnormal—Citalopram—alcohol dependence	0.000744	0.00448	CcSEcCtD
Cyclobenzaprine—Paraesthesia—Disulfiram—alcohol dependence	0.000739	0.00444	CcSEcCtD
Cyclobenzaprine—Somnolence—Disulfiram—alcohol dependence	0.000732	0.0044	CcSEcCtD
Cyclobenzaprine—Gastritis—Acamprosate—alcohol dependence	0.00073	0.00439	CcSEcCtD
Cyclobenzaprine—Dysarthria—Citalopram—alcohol dependence	0.00072	0.00433	CcSEcCtD
Cyclobenzaprine—Fatigue—Disulfiram—alcohol dependence	0.000709	0.00427	CcSEcCtD
Cyclobenzaprine—Eosinophilia—Acamprosate—alcohol dependence	0.000706	0.00425	CcSEcCtD
Cyclobenzaprine—Gait disturbance—Citalopram—alcohol dependence	0.000698	0.0042	CcSEcCtD
Cyclobenzaprine—Coordination abnormal—Citalopram—alcohol dependence	0.000694	0.00417	CcSEcCtD
Cyclobenzaprine—Muscle twitching—Citalopram—alcohol dependence	0.000694	0.00417	CcSEcCtD
Cyclobenzaprine—Pollakiuria—Acamprosate—alcohol dependence	0.000658	0.00396	CcSEcCtD
Cyclobenzaprine—Nightmare—Citalopram—alcohol dependence	0.000658	0.00396	CcSEcCtD
Cyclobenzaprine—Erectile dysfunction—Acamprosate—alcohol dependence	0.000657	0.00395	CcSEcCtD
Cyclobenzaprine—Weight increased—Acamprosate—alcohol dependence	0.000649	0.0039	CcSEcCtD
Cyclobenzaprine—Upper respiratory tract infection—Naltrexone—alcohol dependence	0.000627	0.00377	CcSEcCtD
Cyclobenzaprine—Acute coronary syndrome—Acamprosate—alcohol dependence	0.000627	0.00377	CcSEcCtD
Cyclobenzaprine—Myocardial infarction—Acamprosate—alcohol dependence	0.000623	0.00375	CcSEcCtD
Cyclobenzaprine—Stomatitis—Acamprosate—alcohol dependence	0.00062	0.00373	CcSEcCtD
Cyclobenzaprine—Weight increased—Naltrexone—alcohol dependence	0.000614	0.00369	CcSEcCtD
Cyclobenzaprine—Gynaecomastia—Citalopram—alcohol dependence	0.000609	0.00367	CcSEcCtD
Cyclobenzaprine—Sweating—Acamprosate—alcohol dependence	0.000609	0.00367	CcSEcCtD
Cyclobenzaprine—Hypertonia—Citalopram—alcohol dependence	0.000597	0.00359	CcSEcCtD
Cyclobenzaprine—Acute coronary syndrome—Naltrexone—alcohol dependence	0.000593	0.00357	CcSEcCtD
Cyclobenzaprine—Mental disability—Citalopram—alcohol dependence	0.000591	0.00356	CcSEcCtD
Cyclobenzaprine—Asthenia—Disulfiram—alcohol dependence	0.00059	0.00355	CcSEcCtD
Cyclobenzaprine—HTR2A—brainstem—alcohol dependence	0.00059	0.0215	CbGeAlD
Cyclobenzaprine—Myocardial infarction—Naltrexone—alcohol dependence	0.000589	0.00355	CcSEcCtD
Cyclobenzaprine—CYP1A2—Fatty Acid Omega Oxidation—CYP2E1—alcohol dependence	0.000586	0.00768	CbGpPWpGaD
Cyclobenzaprine—Euphoric mood—Citalopram—alcohol dependence	0.000585	0.00352	CcSEcCtD
Cyclobenzaprine—CYP2D6—Xenobiotics—CYP2E1—alcohol dependence	0.000579	0.00758	CbGpPWpGaD
Cyclobenzaprine—Hepatitis—Acamprosate—alcohol dependence	0.000571	0.00343	CcSEcCtD
Cyclobenzaprine—HTR2A—forebrain—alcohol dependence	0.00057	0.0207	CbGeAlD
Cyclobenzaprine—Hypoaesthesia—Acamprosate—alcohol dependence	0.000568	0.00341	CcSEcCtD
Cyclobenzaprine—Hallucination—Acamprosate—alcohol dependence	0.000568	0.00341	CcSEcCtD
Cyclobenzaprine—Pharyngitis—Acamprosate—alcohol dependence	0.000566	0.00341	CcSEcCtD
Cyclobenzaprine—CYP3A4—Fatty Acid Omega Oxidation—ALDH2—alcohol dependence	0.000566	0.00741	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Amine ligand-binding receptors—DRD4—alcohol dependence	0.000565	0.00741	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Phase 1 - Functionalization of compounds—ADH6—alcohol dependence	0.000558	0.00731	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Tamoxifen metabolism—CYP2E1—alcohol dependence	0.000557	0.00729	CbGpPWpGaD
Cyclobenzaprine—Vascular purpura—Citalopram—alcohol dependence	0.000553	0.00332	CcSEcCtD
Cyclobenzaprine—Disorientation—Citalopram—alcohol dependence	0.000553	0.00332	CcSEcCtD
Cyclobenzaprine—CYP2D6—Phase 1 - Functionalization of compounds—ADH1A—alcohol dependence	0.000546	0.00715	CbGpPWpGaD
Cyclobenzaprine—Dizziness—Disulfiram—alcohol dependence	0.000544	0.00327	CcSEcCtD
Cyclobenzaprine—Hepatitis—Naltrexone—alcohol dependence	0.00054	0.00325	CcSEcCtD
Cyclobenzaprine—CYP2D6—brainstem—alcohol dependence	0.000538	0.0196	CbGeAlD
Cyclobenzaprine—Hallucination—Naltrexone—alcohol dependence	0.000537	0.00323	CcSEcCtD
Cyclobenzaprine—Pharyngitis—Naltrexone—alcohol dependence	0.000536	0.00322	CcSEcCtD
Cyclobenzaprine—Libido decreased—Citalopram—alcohol dependence	0.000533	0.00321	CcSEcCtD
Cyclobenzaprine—Tinnitus—Acamprosate—alcohol dependence	0.000532	0.0032	CcSEcCtD
Cyclobenzaprine—HTR2A—Amine ligand-binding receptors—HTR7—alcohol dependence	0.000526	0.0069	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Amine ligand-binding receptors—DRD2—alcohol dependence	0.000526	0.0069	CbGpPWpGaD
Cyclobenzaprine—Thirst—Citalopram—alcohol dependence	0.00052	0.00313	CcSEcCtD
Cyclobenzaprine—CYP2D6—forebrain—alcohol dependence	0.000519	0.0189	CbGeAlD
Cyclobenzaprine—Rash—Disulfiram—alcohol dependence	0.000519	0.00312	CcSEcCtD
Cyclobenzaprine—Headache—Disulfiram—alcohol dependence	0.000516	0.0031	CcSEcCtD
Cyclobenzaprine—Purpura—Citalopram—alcohol dependence	0.000513	0.00309	CcSEcCtD
Cyclobenzaprine—CYP1A2—digestive system—alcohol dependence	0.000511	0.0186	CbGeAlD
Cyclobenzaprine—Cerebrovascular accident—Citalopram—alcohol dependence	0.000505	0.00304	CcSEcCtD
Cyclobenzaprine—Alopecia—Acamprosate—alcohol dependence	0.000504	0.00303	CcSEcCtD
Cyclobenzaprine—Tinnitus—Naltrexone—alcohol dependence	0.000503	0.00303	CcSEcCtD
Cyclobenzaprine—Diplopia—Citalopram—alcohol dependence	0.000494	0.00297	CcSEcCtD
Cyclobenzaprine—Osteoarthritis—Citalopram—alcohol dependence	0.000494	0.00297	CcSEcCtD
Cyclobenzaprine—Disturbance in sexual arousal—Citalopram—alcohol dependence	0.000491	0.00295	CcSEcCtD
Cyclobenzaprine—CYP1A2—Xenobiotics—CYP2E1—alcohol dependence	0.00049	0.00642	CbGpPWpGaD
Cyclobenzaprine—Flatulence—Acamprosate—alcohol dependence	0.000489	0.00294	CcSEcCtD
Cyclobenzaprine—Tension—Acamprosate—alcohol dependence	0.000487	0.00293	CcSEcCtD
Cyclobenzaprine—CYP1A2—blood—alcohol dependence	0.000487	0.0177	CbGeAlD
Cyclobenzaprine—Dysgeusia—Acamprosate—alcohol dependence	0.000486	0.00293	CcSEcCtD
Cyclobenzaprine—Psychotic disorder—Citalopram—alcohol dependence	0.000483	0.0029	CcSEcCtD
Cyclobenzaprine—Nervousness—Acamprosate—alcohol dependence	0.000482	0.0029	CcSEcCtD
Cyclobenzaprine—HTR2A—cardiovascular system—alcohol dependence	0.000482	0.0175	CbGeAlD
Cyclobenzaprine—Face oedema—Citalopram—alcohol dependence	0.000477	0.00287	CcSEcCtD
Cyclobenzaprine—Alopecia—Naltrexone—alcohol dependence	0.000477	0.00287	CcSEcCtD
Cyclobenzaprine—Irritability—Citalopram—alcohol dependence	0.000472	0.00284	CcSEcCtD
Cyclobenzaprine—CYP1A2—Tamoxifen metabolism—CYP2E1—alcohol dependence	0.000471	0.00618	CbGpPWpGaD
Cyclobenzaprine—Urinary retention—Citalopram—alcohol dependence	0.00047	0.00283	CcSEcCtD
Cyclobenzaprine—CYP1A2—Aflatoxin activation and detoxification—GGT1—alcohol dependence	0.000469	0.00615	CbGpPWpGaD
Cyclobenzaprine—Tremor—Acamprosate—alcohol dependence	0.000465	0.0028	CcSEcCtD
Cyclobenzaprine—Ataxia—Citalopram—alcohol dependence	0.000465	0.0028	CcSEcCtD
Cyclobenzaprine—CYP2D6—Phase 1 - Functionalization of compounds—ADH4—alcohol dependence	0.000464	0.00608	CbGpPWpGaD
Cyclobenzaprine—Flatulence—Naltrexone—alcohol dependence	0.000463	0.00279	CcSEcCtD
Cyclobenzaprine—CYP1A2—Phase 1 - Functionalization of compounds—ADH1A—alcohol dependence	0.000462	0.00606	CbGpPWpGaD
Cyclobenzaprine—Tension—Naltrexone—alcohol dependence	0.000461	0.00277	CcSEcCtD
Cyclobenzaprine—Ill-defined disorder—Acamprosate—alcohol dependence	0.000461	0.00277	CcSEcCtD
Cyclobenzaprine—Dysgeusia—Naltrexone—alcohol dependence	0.00046	0.00277	CcSEcCtD
Cyclobenzaprine—Agitation—Acamprosate—alcohol dependence	0.000456	0.00275	CcSEcCtD
Cyclobenzaprine—Nervousness—Naltrexone—alcohol dependence	0.000456	0.00275	CcSEcCtD
Cyclobenzaprine—Angioedema—Acamprosate—alcohol dependence	0.000454	0.00273	CcSEcCtD
Cyclobenzaprine—CYP3A4—Fatty Acid Omega Oxidation—CYP2E1—alcohol dependence	0.000452	0.00593	CbGpPWpGaD
Cyclobenzaprine—Malaise—Acamprosate—alcohol dependence	0.000448	0.00269	CcSEcCtD
Cyclobenzaprine—Vertigo—Acamprosate—alcohol dependence	0.000446	0.00268	CcSEcCtD
Cyclobenzaprine—Syncope—Acamprosate—alcohol dependence	0.000445	0.00268	CcSEcCtD
Cyclobenzaprine—Leukopenia—Acamprosate—alcohol dependence	0.000445	0.00267	CcSEcCtD
Cyclobenzaprine—Vision blurred—Naltrexone—alcohol dependence	0.000443	0.00266	CcSEcCtD
Cyclobenzaprine—Tremor—Naltrexone—alcohol dependence	0.00044	0.00265	CcSEcCtD
Cyclobenzaprine—Palpitations—Acamprosate—alcohol dependence	0.000439	0.00264	CcSEcCtD
Cyclobenzaprine—Gastritis—Citalopram—alcohol dependence	0.000438	0.00263	CcSEcCtD
Cyclobenzaprine—HTR2A—gonad—alcohol dependence	0.000437	0.0159	CbGeAlD
Cyclobenzaprine—Loss of consciousness—Acamprosate—alcohol dependence	0.000437	0.00263	CcSEcCtD
Cyclobenzaprine—Ill-defined disorder—Naltrexone—alcohol dependence	0.000436	0.00262	CcSEcCtD
Cyclobenzaprine—Agitation—Naltrexone—alcohol dependence	0.000432	0.0026	CcSEcCtD
Cyclobenzaprine—CYP3A4—Phase 1 - Functionalization of compounds—ADH6—alcohol dependence	0.00043	0.00564	CbGpPWpGaD
Cyclobenzaprine—Convulsion—Acamprosate—alcohol dependence	0.00043	0.00259	CcSEcCtD
Cyclobenzaprine—Angioedema—Naltrexone—alcohol dependence	0.000429	0.00258	CcSEcCtD
Cyclobenzaprine—Hypertension—Acamprosate—alcohol dependence	0.000429	0.00258	CcSEcCtD
Cyclobenzaprine—Malaise—Naltrexone—alcohol dependence	0.000424	0.00255	CcSEcCtD
Cyclobenzaprine—Eosinophilia—Citalopram—alcohol dependence	0.000423	0.00255	CcSEcCtD
Cyclobenzaprine—Myalgia—Acamprosate—alcohol dependence	0.000423	0.00254	CcSEcCtD
Cyclobenzaprine—Chest pain—Acamprosate—alcohol dependence	0.000423	0.00254	CcSEcCtD
Cyclobenzaprine—CYP1A2—endocrine gland—alcohol dependence	0.000423	0.0154	CbGeAlD
Cyclobenzaprine—Syncope—Naltrexone—alcohol dependence	0.000421	0.00254	CcSEcCtD
Cyclobenzaprine—Anxiety—Acamprosate—alcohol dependence	0.000421	0.00253	CcSEcCtD
Cyclobenzaprine—HTR2A—GPCRs, Other—CHRM2—alcohol dependence	0.000419	0.00549	CbGpPWpGaD
Cyclobenzaprine—Discomfort—Acamprosate—alcohol dependence	0.000418	0.00251	CcSEcCtD
Cyclobenzaprine—Palpitations—Naltrexone—alcohol dependence	0.000415	0.0025	CcSEcCtD
Cyclobenzaprine—Dry mouth—Acamprosate—alcohol dependence	0.000414	0.00249	CcSEcCtD
Cyclobenzaprine—Loss of consciousness—Naltrexone—alcohol dependence	0.000413	0.00248	CcSEcCtD
Cyclobenzaprine—Confusional state—Acamprosate—alcohol dependence	0.000409	0.00246	CcSEcCtD
Cyclobenzaprine—Convulsion—Naltrexone—alcohol dependence	0.000407	0.00245	CcSEcCtD
Cyclobenzaprine—Pancytopenia—Citalopram—alcohol dependence	0.000406	0.00244	CcSEcCtD
Cyclobenzaprine—Hypertension—Naltrexone—alcohol dependence	0.000406	0.00244	CcSEcCtD
Cyclobenzaprine—Anaphylactic shock—Acamprosate—alcohol dependence	0.000405	0.00244	CcSEcCtD
Cyclobenzaprine—Chest pain—Naltrexone—alcohol dependence	0.0004	0.00241	CcSEcCtD
Cyclobenzaprine—Myalgia—Naltrexone—alcohol dependence	0.0004	0.00241	CcSEcCtD
Cyclobenzaprine—HTR2A—digestive system—alcohol dependence	0.0004	0.0146	CbGeAlD
Cyclobenzaprine—Shock—Acamprosate—alcohol dependence	0.000399	0.0024	CcSEcCtD
Cyclobenzaprine—Anxiety—Naltrexone—alcohol dependence	0.000399	0.0024	CcSEcCtD
Cyclobenzaprine—Upper respiratory tract infection—Citalopram—alcohol dependence	0.000397	0.00239	CcSEcCtD
Cyclobenzaprine—Thrombocytopenia—Acamprosate—alcohol dependence	0.000397	0.00239	CcSEcCtD
Cyclobenzaprine—Tachycardia—Acamprosate—alcohol dependence	0.000396	0.00238	CcSEcCtD
Cyclobenzaprine—Discomfort—Naltrexone—alcohol dependence	0.000395	0.00238	CcSEcCtD
Cyclobenzaprine—Pollakiuria—Citalopram—alcohol dependence	0.000395	0.00237	CcSEcCtD
Cyclobenzaprine—CYP2D6—Phase 1 - Functionalization of compounds—ADH7—alcohol dependence	0.000394	0.00517	CbGpPWpGaD
Cyclobenzaprine—Erectile dysfunction—Citalopram—alcohol dependence	0.000394	0.00237	CcSEcCtD
Cyclobenzaprine—CYP1A2—Phase 1 - Functionalization of compounds—ADH4—alcohol dependence	0.000393	0.00515	CbGpPWpGaD
Cyclobenzaprine—Hyperhidrosis—Acamprosate—alcohol dependence	0.000392	0.00236	CcSEcCtD
Cyclobenzaprine—Dry mouth—Naltrexone—alcohol dependence	0.000391	0.00235	CcSEcCtD
Cyclobenzaprine—Weight increased—Citalopram—alcohol dependence	0.000389	0.00234	CcSEcCtD
Cyclobenzaprine—Confusional state—Naltrexone—alcohol dependence	0.000387	0.00233	CcSEcCtD
Cyclobenzaprine—Anorexia—Acamprosate—alcohol dependence	0.000386	0.00232	CcSEcCtD
Cyclobenzaprine—Anaphylactic shock—Naltrexone—alcohol dependence	0.000384	0.00231	CcSEcCtD
Cyclobenzaprine—Oedema—Naltrexone—alcohol dependence	0.000384	0.00231	CcSEcCtD
Cyclobenzaprine—Dimetindene—CHRM2—alcohol dependence	0.000383	0.0583	CrCbGaD
Cyclobenzaprine—CYP1A2—liver—alcohol dependence	0.000381	0.0139	CbGeAlD
Cyclobenzaprine—HTR2A—blood—alcohol dependence	0.000381	0.0139	CbGeAlD
Cyclobenzaprine—Hypotension—Acamprosate—alcohol dependence	0.000379	0.00228	CcSEcCtD
Cyclobenzaprine—CYP3A4—Xenobiotics—CYP2E1—alcohol dependence	0.000378	0.00496	CbGpPWpGaD
Cyclobenzaprine—Shock—Naltrexone—alcohol dependence	0.000377	0.00227	CcSEcCtD
Cyclobenzaprine—HTR2A—midbrain—alcohol dependence	0.000376	0.0137	CbGeAlD
Cyclobenzaprine—Acute coronary syndrome—Citalopram—alcohol dependence	0.000376	0.00226	CcSEcCtD
Cyclobenzaprine—Tachycardia—Naltrexone—alcohol dependence	0.000374	0.00225	CcSEcCtD
Cyclobenzaprine—Neuropathy peripheral—Citalopram—alcohol dependence	0.000373	0.00225	CcSEcCtD
Cyclobenzaprine—Myocardial infarction—Citalopram—alcohol dependence	0.000373	0.00225	CcSEcCtD
Cyclobenzaprine—Jaundice—Citalopram—alcohol dependence	0.000371	0.00223	CcSEcCtD
Cyclobenzaprine—Stomatitis—Citalopram—alcohol dependence	0.000371	0.00223	CcSEcCtD
Cyclobenzaprine—Hyperhidrosis—Naltrexone—alcohol dependence	0.000371	0.00223	CcSEcCtD
Cyclobenzaprine—CYP1A2—Tryptophan metabolism—MAOB—alcohol dependence	0.00037	0.00485	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—digestive system—alcohol dependence	0.00037	0.0135	CbGeAlD
Cyclobenzaprine—Musculoskeletal discomfort—Acamprosate—alcohol dependence	0.000369	0.00222	CcSEcCtD
Cyclobenzaprine—Insomnia—Acamprosate—alcohol dependence	0.000367	0.00221	CcSEcCtD
Cyclobenzaprine—Anorexia—Naltrexone—alcohol dependence	0.000366	0.0022	CcSEcCtD
Cyclobenzaprine—Sweating—Citalopram—alcohol dependence	0.000365	0.0022	CcSEcCtD
Cyclobenzaprine—CYP2D6—digestive system—alcohol dependence	0.000364	0.0133	CbGeAlD
Cyclobenzaprine—Paraesthesia—Acamprosate—alcohol dependence	0.000364	0.00219	CcSEcCtD
Cyclobenzaprine—CYP3A4—Tamoxifen metabolism—CYP2E1—alcohol dependence	0.000364	0.00477	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Aflatoxin activation and detoxification—GGT1—alcohol dependence	0.000362	0.00474	CbGpPWpGaD
Cyclobenzaprine—Dyspnoea—Acamprosate—alcohol dependence	0.000361	0.00217	CcSEcCtD
Cyclobenzaprine—Somnolence—Acamprosate—alcohol dependence	0.00036	0.00217	CcSEcCtD
Cyclobenzaprine—Dyspepsia—Acamprosate—alcohol dependence	0.000357	0.00215	CcSEcCtD
Cyclobenzaprine—CYP3A4—Phase 1 - Functionalization of compounds—ADH1A—alcohol dependence	0.000357	0.00467	CbGpPWpGaD
Cyclobenzaprine—Agranulocytosis—Citalopram—alcohol dependence	0.000356	0.00214	CcSEcCtD
Cyclobenzaprine—CYP2D6—Melatonin metabolism and effects—MAOA—alcohol dependence	0.000354	0.00464	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—blood—alcohol dependence	0.000353	0.0128	CbGeAlD
Cyclobenzaprine—Decreased appetite—Acamprosate—alcohol dependence	0.000352	0.00212	CcSEcCtD
Cyclobenzaprine—CYP2D6—Biological oxidations—ADH6—alcohol dependence	0.00035	0.00458	CbGpPWpGaD
Cyclobenzaprine—Musculoskeletal discomfort—Naltrexone—alcohol dependence	0.000349	0.0021	CcSEcCtD
Cyclobenzaprine—CYP2D6—blood—alcohol dependence	0.000347	0.0126	CbGeAlD
Cyclobenzaprine—Insomnia—Naltrexone—alcohol dependence	0.000347	0.00209	CcSEcCtD
Cyclobenzaprine—Constipation—Acamprosate—alcohol dependence	0.000347	0.00209	CcSEcCtD
Cyclobenzaprine—CYP2D6—Phase 1 - Functionalization of compounds—ADH1B—alcohol dependence	0.000346	0.00453	CbGpPWpGaD
Cyclobenzaprine—Paraesthesia—Naltrexone—alcohol dependence	0.000344	0.00207	CcSEcCtD
Cyclobenzaprine—Hepatitis—Citalopram—alcohol dependence	0.000342	0.00206	CcSEcCtD
Cyclobenzaprine—Dyspnoea—Naltrexone—alcohol dependence	0.000342	0.00206	CcSEcCtD
Cyclobenzaprine—Somnolence—Naltrexone—alcohol dependence	0.000341	0.00205	CcSEcCtD
Cyclobenzaprine—Hypoaesthesia—Citalopram—alcohol dependence	0.00034	0.00205	CcSEcCtD
Cyclobenzaprine—Hallucination—Citalopram—alcohol dependence	0.00034	0.00205	CcSEcCtD
Cyclobenzaprine—Pharyngitis—Citalopram—alcohol dependence	0.000339	0.00204	CcSEcCtD
Cyclobenzaprine—CYP1A2—Phase 1 - Functionalization of compounds—ADH7—alcohol dependence	0.000334	0.00438	CbGpPWpGaD
Cyclobenzaprine—Feeling abnormal—Acamprosate—alcohol dependence	0.000334	0.00201	CcSEcCtD
Cyclobenzaprine—Decreased appetite—Naltrexone—alcohol dependence	0.000333	0.00201	CcSEcCtD
Cyclobenzaprine—Gastrointestinal pain—Acamprosate—alcohol dependence	0.000331	0.00199	CcSEcCtD
Cyclobenzaprine—Fatigue—Naltrexone—alcohol dependence	0.000331	0.00199	CcSEcCtD
Cyclobenzaprine—HTR2A—endocrine gland—alcohol dependence	0.00033	0.012	CbGeAlD
Cyclobenzaprine—Constipation—Naltrexone—alcohol dependence	0.000328	0.00197	CcSEcCtD
Cyclobenzaprine—HTR2A—GPCRs, Class A Rhodopsin-like—OPRK1—alcohol dependence	0.000323	0.00424	CbGpPWpGaD
Cyclobenzaprine—Urticaria—Acamprosate—alcohol dependence	0.000322	0.00194	CcSEcCtD
Cyclobenzaprine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—alcohol dependence	0.000321	0.0042	CbGpPWpGaD
Cyclobenzaprine—Abdominal pain—Acamprosate—alcohol dependence	0.00032	0.00193	CcSEcCtD
Cyclobenzaprine—Tinnitus—Citalopram—alcohol dependence	0.000319	0.00192	CcSEcCtD
Cyclobenzaprine—Feeling abnormal—Naltrexone—alcohol dependence	0.000316	0.0019	CcSEcCtD
Cyclobenzaprine—HTR2A—testis—alcohol dependence	0.000315	0.0115	CbGeAlD
Cyclobenzaprine—CYP1A2—Tryptophan metabolism—ALDH2—alcohol dependence	0.000315	0.00413	CbGpPWpGaD
Cyclobenzaprine—Gastrointestinal pain—Naltrexone—alcohol dependence	0.000314	0.00189	CcSEcCtD
Cyclobenzaprine—HTR2A—nervous system—alcohol dependence	0.000309	0.0113	CbGeAlD
Cyclobenzaprine—CYP3A4—endocrine gland—alcohol dependence	0.000306	0.0111	CbGeAlD
Cyclobenzaprine—Arrhythmia—Citalopram—alcohol dependence	0.000306	0.00184	CcSEcCtD
Cyclobenzaprine—Urticaria—Naltrexone—alcohol dependence	0.000305	0.00183	CcSEcCtD
Cyclobenzaprine—CYP3A4—Phase 1 - Functionalization of compounds—ADH4—alcohol dependence	0.000303	0.00397	CbGpPWpGaD
Cyclobenzaprine—Abdominal pain—Naltrexone—alcohol dependence	0.000303	0.00182	CcSEcCtD
Cyclobenzaprine—Alopecia—Citalopram—alcohol dependence	0.000302	0.00182	CcSEcCtD
Cyclobenzaprine—Protriptyline—SLC6A4—alcohol dependence	0.000302	0.046	CrCbGaD
Cyclobenzaprine—CYP2D6—endocrine gland—alcohol dependence	0.000301	0.011	CbGeAlD
Cyclobenzaprine—CYP1A2—Melatonin metabolism and effects—MAOA—alcohol dependence	0.0003	0.00393	CbGpPWpGaD
Cyclobenzaprine—Hypersensitivity—Acamprosate—alcohol dependence	0.000299	0.0018	CcSEcCtD
Cyclobenzaprine—HTR2A—GPCRs, Other—DRD4—alcohol dependence	0.000299	0.00391	CbGpPWpGaD
Cyclobenzaprine—HTR2A—liver—alcohol dependence	0.000298	0.0108	CbGeAlD
Cyclobenzaprine—HTR2A—central nervous system—alcohol dependence	0.000298	0.0108	CbGeAlD
Cyclobenzaprine—CYP1A2—Biological oxidations—ADH6—alcohol dependence	0.000296	0.00388	CbGpPWpGaD
Cyclobenzaprine—Flatulence—Citalopram—alcohol dependence	0.000293	0.00176	CcSEcCtD
Cyclobenzaprine—CYP1A2—Phase 1 - Functionalization of compounds—ADH1B—alcohol dependence	0.000293	0.00384	CbGpPWpGaD
Cyclobenzaprine—Tension—Citalopram—alcohol dependence	0.000292	0.00176	CcSEcCtD
Cyclobenzaprine—Dysgeusia—Citalopram—alcohol dependence	0.000292	0.00175	CcSEcCtD
Cyclobenzaprine—HTR2A—cerebellum—alcohol dependence	0.000291	0.0106	CbGeAlD
Cyclobenzaprine—CYP1A2—Phase II conjugation—GGT2—alcohol dependence	0.000291	0.00381	CbGpPWpGaD
Cyclobenzaprine—Asthenia—Acamprosate—alcohol dependence	0.000291	0.00175	CcSEcCtD
Cyclobenzaprine—CYP2D6—Biological oxidations—ADH1A—alcohol dependence	0.00029	0.0038	CbGpPWpGaD
Cyclobenzaprine—Nervousness—Citalopram—alcohol dependence	0.000289	0.00174	CcSEcCtD
Cyclobenzaprine—CYP2D6—testis—alcohol dependence	0.000287	0.0105	CbGeAlD
Cyclobenzaprine—Pruritus—Acamprosate—alcohol dependence	0.000287	0.00173	CcSEcCtD
Cyclobenzaprine—CYP2D6—Phase 1 - Functionalization of compounds—MAOB—alcohol dependence	0.000287	0.00376	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—nervous system—alcohol dependence	0.000286	0.0104	CbGeAlD
Cyclobenzaprine—CYP3A4—Tryptophan metabolism—MAOB—alcohol dependence	0.000286	0.00375	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCRs, Other—CNR1—alcohol dependence	0.000285	0.00374	CbGpPWpGaD
Cyclobenzaprine—Hypersensitivity—Naltrexone—alcohol dependence	0.000283	0.0017	CcSEcCtD
Cyclobenzaprine—CYP2D6—nervous system—alcohol dependence	0.000282	0.0103	CbGeAlD
Cyclobenzaprine—Vision blurred—Citalopram—alcohol dependence	0.000281	0.00169	CcSEcCtD
Cyclobenzaprine—Tremor—Citalopram—alcohol dependence	0.000279	0.00168	CcSEcCtD
Cyclobenzaprine—HTR2A—GPCRs, Other—HTR7—alcohol dependence	0.000278	0.00365	CbGpPWpGaD
Cyclobenzaprine—Diarrhoea—Acamprosate—alcohol dependence	0.000277	0.00167	CcSEcCtD
Cyclobenzaprine—HTR2A—Class A/1 (Rhodopsin-like receptors)—OPRK1—alcohol dependence	0.000277	0.00363	CbGpPWpGaD
Cyclobenzaprine—Ill-defined disorder—Citalopram—alcohol dependence	0.000276	0.00166	CcSEcCtD
Cyclobenzaprine—CYP3A4—liver—alcohol dependence	0.000276	0.01	CbGeAlD
Cyclobenzaprine—CYP3A4—central nervous system—alcohol dependence	0.000276	0.01	CbGeAlD
Cyclobenzaprine—Asthenia—Naltrexone—alcohol dependence	0.000275	0.00166	CcSEcCtD
Cyclobenzaprine—Agitation—Citalopram—alcohol dependence	0.000274	0.00165	CcSEcCtD
Cyclobenzaprine—HTR2A—SIDS Susceptibility Pathways—CHRM2—alcohol dependence	0.000272	0.00357	CbGpPWpGaD
Cyclobenzaprine—Angioedema—Citalopram—alcohol dependence	0.000272	0.00164	CcSEcCtD
Cyclobenzaprine—CYP2D6—liver—alcohol dependence	0.000271	0.00988	CbGeAlD
Cyclobenzaprine—Pruritus—Naltrexone—alcohol dependence	0.000271	0.00163	CcSEcCtD
Cyclobenzaprine—CYP2D6—central nervous system—alcohol dependence	0.000271	0.00987	CbGeAlD
Cyclobenzaprine—Amitriptyline—OPRK1—alcohol dependence	0.00027	0.0412	CrCbGaD
Cyclobenzaprine—Malaise—Citalopram—alcohol dependence	0.000269	0.00162	CcSEcCtD
Cyclobenzaprine—Dizziness—Acamprosate—alcohol dependence	0.000268	0.00161	CcSEcCtD
Cyclobenzaprine—Vertigo—Citalopram—alcohol dependence	0.000268	0.00161	CcSEcCtD
Cyclobenzaprine—Syncope—Citalopram—alcohol dependence	0.000267	0.00161	CcSEcCtD
Cyclobenzaprine—Leukopenia—Citalopram—alcohol dependence	0.000267	0.0016	CcSEcCtD
Cyclobenzaprine—CYP2D6—cerebellum—alcohol dependence	0.000265	0.00965	CbGeAlD
Cyclobenzaprine—Palpitations—Citalopram—alcohol dependence	0.000263	0.00158	CcSEcCtD
Cyclobenzaprine—Cyproheptadine—CHRM2—alcohol dependence	0.000262	0.04	CrCbGaD
Cyclobenzaprine—Diarrhoea—Naltrexone—alcohol dependence	0.000262	0.00158	CcSEcCtD
Cyclobenzaprine—Loss of consciousness—Citalopram—alcohol dependence	0.000262	0.00157	CcSEcCtD
Cyclobenzaprine—Convulsion—Citalopram—alcohol dependence	0.000258	0.00155	CcSEcCtD
Cyclobenzaprine—CYP3A4—Phase 1 - Functionalization of compounds—ADH7—alcohol dependence	0.000258	0.00338	CbGpPWpGaD
Cyclobenzaprine—Vomiting—Acamprosate—alcohol dependence	0.000258	0.00155	CcSEcCtD
Cyclobenzaprine—Hypertension—Citalopram—alcohol dependence	0.000257	0.00155	CcSEcCtD
Cyclobenzaprine—Rash—Acamprosate—alcohol dependence	0.000256	0.00154	CcSEcCtD
Cyclobenzaprine—Dermatitis—Acamprosate—alcohol dependence	0.000255	0.00154	CcSEcCtD
Cyclobenzaprine—Headache—Acamprosate—alcohol dependence	0.000254	0.00153	CcSEcCtD
Cyclobenzaprine—Dizziness—Naltrexone—alcohol dependence	0.000254	0.00153	CcSEcCtD
Cyclobenzaprine—Chest pain—Citalopram—alcohol dependence	0.000253	0.00152	CcSEcCtD
Cyclobenzaprine—Myalgia—Citalopram—alcohol dependence	0.000253	0.00152	CcSEcCtD
Cyclobenzaprine—Anxiety—Citalopram—alcohol dependence	0.000253	0.00152	CcSEcCtD
Cyclobenzaprine—CYP1A2—Tryptophan metabolism—CYP2E1—alcohol dependence	0.000252	0.0033	CbGpPWpGaD
Cyclobenzaprine—Discomfort—Citalopram—alcohol dependence	0.00025	0.00151	CcSEcCtD
Cyclobenzaprine—Dry mouth—Citalopram—alcohol dependence	0.000248	0.00149	CcSEcCtD
Cyclobenzaprine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—alcohol dependence	0.000247	0.00324	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Biological oxidations—ADH4—alcohol dependence	0.000246	0.00323	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Biological oxidations—ADH1A—alcohol dependence	0.000245	0.00322	CbGpPWpGaD
Cyclobenzaprine—Confusional state—Citalopram—alcohol dependence	0.000245	0.00147	CcSEcCtD
Cyclobenzaprine—Vomiting—Naltrexone—alcohol dependence	0.000244	0.00147	CcSEcCtD
Cyclobenzaprine—CYP2D6—Phase 1 - Functionalization of compounds—ALDH2—alcohol dependence	0.000244	0.00319	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Tryptophan metabolism—ALDH2—alcohol dependence	0.000243	0.00319	CbGpPWpGaD
Cyclobenzaprine—Anaphylactic shock—Citalopram—alcohol dependence	0.000243	0.00146	CcSEcCtD
Cyclobenzaprine—Oedema—Citalopram—alcohol dependence	0.000243	0.00146	CcSEcCtD
Cyclobenzaprine—CYP1A2—Phase 1 - Functionalization of compounds—MAOB—alcohol dependence	0.000243	0.00318	CbGpPWpGaD
Cyclobenzaprine—Rash—Naltrexone—alcohol dependence	0.000242	0.00145	CcSEcCtD
Cyclobenzaprine—Dermatitis—Naltrexone—alcohol dependence	0.000242	0.00145	CcSEcCtD
Cyclobenzaprine—Nausea—Acamprosate—alcohol dependence	0.000241	0.00145	CcSEcCtD
Cyclobenzaprine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2E1—alcohol dependence	0.00024	0.00315	CbGpPWpGaD
Cyclobenzaprine—Headache—Naltrexone—alcohol dependence	0.00024	0.00145	CcSEcCtD
Cyclobenzaprine—Shock—Citalopram—alcohol dependence	0.000239	0.00144	CcSEcCtD
Cyclobenzaprine—Thrombocytopenia—Citalopram—alcohol dependence	0.000238	0.00143	CcSEcCtD
Cyclobenzaprine—Tachycardia—Citalopram—alcohol dependence	0.000237	0.00143	CcSEcCtD
Cyclobenzaprine—CYP2D6—Oxidation by Cytochrome P450—CYP2E1—alcohol dependence	0.000237	0.00311	CbGpPWpGaD
Cyclobenzaprine—HTR2A—brain—alcohol dependence	0.000236	0.00861	CbGeAlD
Cyclobenzaprine—Hyperhidrosis—Citalopram—alcohol dependence	0.000235	0.00141	CcSEcCtD
Cyclobenzaprine—Anorexia—Citalopram—alcohol dependence	0.000232	0.00139	CcSEcCtD
Cyclobenzaprine—CYP3A4—Biological oxidations—ADH6—alcohol dependence	0.000229	0.003	CbGpPWpGaD
Cyclobenzaprine—Nausea—Naltrexone—alcohol dependence	0.000228	0.00137	CcSEcCtD
Cyclobenzaprine—Hypotension—Citalopram—alcohol dependence	0.000227	0.00137	CcSEcCtD
Cyclobenzaprine—CYP3A4—Phase 1 - Functionalization of compounds—ADH1B—alcohol dependence	0.000226	0.00296	CbGpPWpGaD
Cyclobenzaprine—Musculoskeletal discomfort—Citalopram—alcohol dependence	0.000221	0.00133	CcSEcCtD
Cyclobenzaprine—Insomnia—Citalopram—alcohol dependence	0.00022	0.00132	CcSEcCtD
Cyclobenzaprine—Paraesthesia—Citalopram—alcohol dependence	0.000218	0.00131	CcSEcCtD
Cyclobenzaprine—HTR2A—GPCRs, Class A Rhodopsin-like—OPRD1—alcohol dependence	0.000217	0.00285	CbGpPWpGaD
Cyclobenzaprine—Dyspnoea—Citalopram—alcohol dependence	0.000217	0.0013	CcSEcCtD
Cyclobenzaprine—CYP1A2—Arachidonic acid metabolism—GGT1—alcohol dependence	0.000216	0.00283	CbGpPWpGaD
Cyclobenzaprine—Somnolence—Citalopram—alcohol dependence	0.000216	0.0013	CcSEcCtD
Cyclobenzaprine—CYP2D6—brain—alcohol dependence	0.000215	0.00784	CbGeAlD
Cyclobenzaprine—Dyspepsia—Citalopram—alcohol dependence	0.000214	0.00129	CcSEcCtD
Cyclobenzaprine—Decreased appetite—Citalopram—alcohol dependence	0.000211	0.00127	CcSEcCtD
Cyclobenzaprine—HTR2A—GPCR ligand binding—OPRK1—alcohol dependence	0.000211	0.00276	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Biological oxidations—ADH7—alcohol dependence	0.00021	0.00275	CbGpPWpGaD
Cyclobenzaprine—Fatigue—Citalopram—alcohol dependence	0.00021	0.00126	CcSEcCtD
Cyclobenzaprine—CYP1A2—Biological oxidations—ADH4—alcohol dependence	0.000209	0.00274	CbGpPWpGaD
Cyclobenzaprine—Constipation—Citalopram—alcohol dependence	0.000208	0.00125	CcSEcCtD
Cyclobenzaprine—CYP1A2—Phase 1 - Functionalization of compounds—ALDH2—alcohol dependence	0.000206	0.00271	CbGpPWpGaD
Cyclobenzaprine—HTR2A—SIDS Susceptibility Pathways—SLC6A4—alcohol dependence	0.000206	0.0027	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2E1—alcohol dependence	0.000204	0.00267	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Oxidation by Cytochrome P450—CYP2E1—alcohol dependence	0.000201	0.00263	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Biological oxidations—GGT2—alcohol dependence	0.000201	0.00263	CbGpPWpGaD
Cyclobenzaprine—Feeling abnormal—Citalopram—alcohol dependence	0.0002	0.0012	CcSEcCtD
Cyclobenzaprine—Gastrointestinal pain—Citalopram—alcohol dependence	0.000199	0.0012	CcSEcCtD
Cyclobenzaprine—CYP2D6—Phase 1 - Functionalization of compounds—CYP2E1—alcohol dependence	0.000195	0.00255	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Tryptophan metabolism—CYP2E1—alcohol dependence	0.000194	0.00255	CbGpPWpGaD
Cyclobenzaprine—Urticaria—Citalopram—alcohol dependence	0.000193	0.00116	CcSEcCtD
Cyclobenzaprine—Abdominal pain—Citalopram—alcohol dependence	0.000192	0.00116	CcSEcCtD
Cyclobenzaprine—Amitriptyline—OPRD1—alcohol dependence	0.000191	0.029	CrCbGaD
Cyclobenzaprine—CYP3A4—Biological oxidations—ADH1A—alcohol dependence	0.000189	0.00248	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Phase 1 - Functionalization of compounds—MAOB—alcohol dependence	0.000187	0.00246	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Class A/1 (Rhodopsin-like receptors)—OPRD1—alcohol dependence	0.000186	0.00244	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Biological oxidations—ADH1B—alcohol dependence	0.000184	0.00241	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCRs, Class A Rhodopsin-like—CHRM2—alcohol dependence	0.000182	0.00239	CbGpPWpGaD
Cyclobenzaprine—Chlorprothixene—CHRM2—alcohol dependence	0.000181	0.0276	CrCbGaD
Cyclobenzaprine—Hypersensitivity—Citalopram—alcohol dependence	0.000179	0.00108	CcSEcCtD
Cyclobenzaprine—Benzphetamine—SLC6A3—alcohol dependence	0.000179	0.0272	CrCbGaD
Cyclobenzaprine—HTR2A—Class A/1 (Rhodopsin-like receptors)—PDYN—alcohol dependence	0.000178	0.00234	CbGpPWpGaD
Cyclobenzaprine—Nortriptyline—CHRM2—alcohol dependence	0.000178	0.0271	CrCbGaD
Cyclobenzaprine—CYP1A2—Biological oxidations—ADH7—alcohol dependence	0.000177	0.00233	CbGpPWpGaD
Cyclobenzaprine—Asthenia—Citalopram—alcohol dependence	0.000174	0.00105	CcSEcCtD
Cyclobenzaprine—Pruritus—Citalopram—alcohol dependence	0.000172	0.00103	CcSEcCtD
Cyclobenzaprine—CYP1A2—Biological oxidations—GGT2—alcohol dependence	0.00017	0.00223	CbGpPWpGaD
Cyclobenzaprine—Cyproheptadine—DRD2—alcohol dependence	0.00017	0.0259	CrCbGaD
Cyclobenzaprine—HTR2A—GPCRs, Class A Rhodopsin-like—OPRM1—alcohol dependence	0.000167	0.00219	CbGpPWpGaD
Cyclobenzaprine—Diarrhoea—Citalopram—alcohol dependence	0.000166	0.001	CcSEcCtD
Cyclobenzaprine—CYP1A2—Phase 1 - Functionalization of compounds—CYP2E1—alcohol dependence	0.000165	0.00216	CbGpPWpGaD
Cyclobenzaprine—Diphenhydramine—CHRM2—alcohol dependence	0.000164	0.025	CrCbGaD
Cyclobenzaprine—Promethazine—CHRM2—alcohol dependence	0.000161	0.0245	CrCbGaD
Cyclobenzaprine—CYP3A4—Biological oxidations—ADH4—alcohol dependence	0.000161	0.00211	CbGpPWpGaD
Cyclobenzaprine—Dizziness—Citalopram—alcohol dependence	0.000161	0.000967	CcSEcCtD
Cyclobenzaprine—CYP2D6—Phase 1 - Functionalization of compounds—MAOA—alcohol dependence	0.00016	0.0021	CbGpPWpGaD
Cyclobenzaprine—Doxepin—CHRM2—alcohol dependence	0.00016	0.0243	CrCbGaD
Cyclobenzaprine—CYP3A4—Phase 1 - Functionalization of compounds—ALDH2—alcohol dependence	0.000159	0.00209	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—alcohol dependence	0.000157	0.00206	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Class A/1 (Rhodopsin-like receptors)—CHRM2—alcohol dependence	0.000156	0.00204	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Biological oxidations—ADH1B—alcohol dependence	0.000156	0.00204	CbGpPWpGaD
Cyclobenzaprine—Orphenadrine—CHRM2—alcohol dependence	0.000155	0.0237	CrCbGaD
Cyclobenzaprine—HTR2A—SIDS Susceptibility Pathways—MAOA—alcohol dependence	0.000155	0.00204	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—alcohol dependence	0.000155	0.00203	CbGpPWpGaD
Cyclobenzaprine—Vomiting—Citalopram—alcohol dependence	0.000155	0.000929	CcSEcCtD
Cyclobenzaprine—Promazine—DRD4—alcohol dependence	0.000154	0.0234	CrCbGaD
Cyclobenzaprine—Rash—Citalopram—alcohol dependence	0.000153	0.000922	CcSEcCtD
Cyclobenzaprine—Dermatitis—Citalopram—alcohol dependence	0.000153	0.000921	CcSEcCtD
Cyclobenzaprine—Headache—Citalopram—alcohol dependence	0.000152	0.000916	CcSEcCtD
Cyclobenzaprine—CYP2D6—Biological oxidations—MAOB—alcohol dependence	0.000152	0.002	CbGpPWpGaD
Cyclobenzaprine—HTR2A—SIDS Susceptibility Pathways—AVP—alcohol dependence	0.000152	0.00199	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCRs, Class A Rhodopsin-like—HTR1B—alcohol dependence	0.000148	0.00195	CbGpPWpGaD
Cyclobenzaprine—Amitriptyline—OPRM1—alcohol dependence	0.000146	0.0222	CrCbGaD
Cyclobenzaprine—Trimipramine—SLC6A3—alcohol dependence	0.000146	0.0222	CrCbGaD
Cyclobenzaprine—Nausea—Citalopram—alcohol dependence	0.000144	0.000868	CcSEcCtD
Cyclobenzaprine—HTR2A—Class A/1 (Rhodopsin-like receptors)—OPRM1—alcohol dependence	0.000143	0.00188	CbGpPWpGaD
Cyclobenzaprine—Promazine—CHRM2—alcohol dependence	0.000142	0.0216	CrCbGaD
Cyclobenzaprine—HTR2A—GPCR ligand binding—OPRD1—alcohol dependence	0.000142	0.00186	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Phase II conjugation—GGT1—alcohol dependence	0.000138	0.0018	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Biological oxidations—ADH7—alcohol dependence	0.000137	0.0018	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR ligand binding—PDYN—alcohol dependence	0.000136	0.00178	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Phase 1 - Functionalization of compounds—MAOA—alcohol dependence	0.000136	0.00178	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Class A/1 (Rhodopsin-like receptors)—NPY—alcohol dependence	0.000132	0.00173	CbGpPWpGaD
Cyclobenzaprine—HTR2A—G alpha (q) signalling events—AVP—alcohol dependence	0.000132	0.00172	CbGpPWpGaD
Cyclobenzaprine—Cyproheptadine—HTR2A—alcohol dependence	0.000131	0.02	CrCbGaD
Cyclobenzaprine—CYP3A4—Biological oxidations—GGT2—alcohol dependence	0.000131	0.00172	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCRs, Class A Rhodopsin-like—DRD4—alcohol dependence	0.00013	0.0017	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Biological oxidations—ALDH2—alcohol dependence	0.000129	0.0017	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Biological oxidations—MAOB—alcohol dependence	0.000129	0.00169	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—alcohol dependence	0.000129	0.00169	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—alcohol dependence	0.000127	0.00167	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Class A/1 (Rhodopsin-like receptors)—HTR1B—alcohol dependence	0.000127	0.00167	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR ligand binding—CRHR1—alcohol dependence	0.000126	0.00166	CbGpPWpGaD
Cyclobenzaprine—Imipramine—CHRM2—alcohol dependence	0.000124	0.0189	CrCbGaD
Cyclobenzaprine—HTR2A—GPCRs, Class A Rhodopsin-like—CNR1—alcohol dependence	0.000124	0.00162	CbGpPWpGaD
Cyclobenzaprine—Imipramine—HTR7—alcohol dependence	0.000124	0.0188	CrCbGaD
Cyclobenzaprine—Amitriptyline—CHRM2—alcohol dependence	0.000123	0.0188	CrCbGaD
Cyclobenzaprine—Amitriptyline—HTR7—alcohol dependence	0.000123	0.0187	CrCbGaD
Cyclobenzaprine—HTR2A—GPCRs, Class A Rhodopsin-like—DRD2—alcohol dependence	0.000121	0.00158	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCRs, Class A Rhodopsin-like—HTR7—alcohol dependence	0.000121	0.00158	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Biological oxidations—ADH1B—alcohol dependence	0.00012	0.00157	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—OPRK1—alcohol dependence	0.000119	0.00156	CbGpPWpGaD
Cyclobenzaprine—Amitriptyline—HTR1B—alcohol dependence	0.000119	0.0181	CrCbGaD
Cyclobenzaprine—HTR2A—GPCR ligand binding—CHRM2—alcohol dependence	0.000119	0.00156	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—AVP—alcohol dependence	0.000118	0.00154	CbGpPWpGaD
Cyclobenzaprine—Chlorprothixene—DRD2—alcohol dependence	0.000117	0.0179	CrCbGaD
Cyclobenzaprine—Nortriptyline—SLC6A4—alcohol dependence	0.000116	0.0176	CrCbGaD
Cyclobenzaprine—Nortriptyline—DRD2—alcohol dependence	0.000115	0.0175	CrCbGaD
Cyclobenzaprine—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD4—alcohol dependence	0.000111	0.00146	CbGpPWpGaD
Cyclobenzaprine—Nortriptyline—CYP2E1—alcohol dependence	0.000111	0.0169	CrCbGaD
Cyclobenzaprine—CYP1A2—Biological oxidations—ALDH2—alcohol dependence	0.00011	0.00144	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR ligand binding—OPRM1—alcohol dependence	0.000109	0.00143	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—alcohol dependence	0.000109	0.00143	CbGpPWpGaD
Cyclobenzaprine—Trimipramine—SLC6A4—alcohol dependence	0.000109	0.0166	CrCbGaD
Cyclobenzaprine—Trimipramine—DRD2—alcohol dependence	0.000108	0.0165	CrCbGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—OPRK1—alcohol dependence	0.000108	0.00142	CbGpPWpGaD
Cyclobenzaprine—Imipramine—SLC6A3—alcohol dependence	0.000108	0.0165	CrCbGaD
Cyclobenzaprine—HTR2A—Class A/1 (Rhodopsin-like receptors)—CNR1—alcohol dependence	0.000106	0.00139	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—alcohol dependence	0.000105	0.00137	CbGpPWpGaD
Cyclobenzaprine—Promethazine—DRD2—alcohol dependence	0.000104	0.0159	CrCbGaD
Cyclobenzaprine—CYP2D6—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	0.000104	0.00137	CbGpPWpGaD
Cyclobenzaprine—Doxepin—SLC6A4—alcohol dependence	0.000104	0.0158	CrCbGaD
Cyclobenzaprine—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD2—alcohol dependence	0.000104	0.00136	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Class A/1 (Rhodopsin-like receptors)—HTR7—alcohol dependence	0.000104	0.00136	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Biological oxidations—CYP2E1—alcohol dependence	0.000103	0.00136	CbGpPWpGaD
Cyclobenzaprine—Doxepin—DRD2—alcohol dependence	0.000103	0.0157	CrCbGaD
Cyclobenzaprine—CYP2D6—Metapathway biotransformation—CYP2E1—alcohol dependence	0.000102	0.00134	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR ligand binding—NPY—alcohol dependence	0.0001	0.00132	CbGpPWpGaD
Cyclobenzaprine—Tamoxifen—CYP2E1—alcohol dependence	9.98e-05	0.0152	CrCbGaD
Cyclobenzaprine—CYP3A4—Biological oxidations—MAOB—alcohol dependence	9.95e-05	0.0013	CbGpPWpGaD
Cyclobenzaprine—Orphenadrine—CYP2E1—alcohol dependence	9.69e-05	0.0148	CrCbGaD
Cyclobenzaprine—HTR2A—GPCR ligand binding—HTR1B—alcohol dependence	9.68e-05	0.00127	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR ligand binding—CRH—alcohol dependence	9.68e-05	0.00127	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Biological oxidations—GGT1—alcohol dependence	9.5e-05	0.00125	CbGpPWpGaD
Cyclobenzaprine—Promazine—DRD2—alcohol dependence	9.18e-05	0.014	CrCbGaD
Cyclobenzaprine—Chlorprothixene—HTR2A—alcohol dependence	9.06e-05	0.0138	CrCbGaD
Cyclobenzaprine—CYP1A2—Aryl Hydrocarbon Receptor—EP300—alcohol dependence	8.95e-05	0.00117	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—alcohol dependence	8.95e-05	0.00117	CbGpPWpGaD
Cyclobenzaprine—Nortriptyline—HTR2A—alcohol dependence	8.9e-05	0.0135	CrCbGaD
Cyclobenzaprine—CYP1A2—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	8.84e-05	0.00116	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Biological oxidations—CYP2E1—alcohol dependence	8.77e-05	0.00115	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Class A/1 (Rhodopsin-like receptors)—AVP—alcohol dependence	8.71e-05	0.00114	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metapathway biotransformation—CYP2E1—alcohol dependence	8.65e-05	0.00113	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Biological oxidations—MAOA—alcohol dependence	8.51e-05	0.00112	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR ligand binding—DRD4—alcohol dependence	8.46e-05	0.00111	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Biological oxidations—ALDH2—alcohol dependence	8.46e-05	0.00111	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—alcohol dependence	8.42e-05	0.0011	CbGpPWpGaD
Cyclobenzaprine—Trimipramine—HTR2A—alcohol dependence	8.38e-05	0.0128	CrCbGaD
Cyclobenzaprine—Imipramine—SLC6A4—alcohol dependence	8.08e-05	0.0123	CrCbGaD
Cyclobenzaprine—HTR2A—GPCR ligand binding—CNR1—alcohol dependence	8.08e-05	0.00106	CbGpPWpGaD
Cyclobenzaprine—Promethazine—HTR2A—alcohol dependence	8.07e-05	0.0123	CrCbGaD
Cyclobenzaprine—CYP1A2—Biological oxidations—GGT1—alcohol dependence	8.05e-05	0.00105	CbGpPWpGaD
Cyclobenzaprine—Imipramine—DRD2—alcohol dependence	8.04e-05	0.0122	CrCbGaD
Cyclobenzaprine—Amitriptyline—SLC6A4—alcohol dependence	8.03e-05	0.0122	CrCbGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—OPRD1—alcohol dependence	8.01e-05	0.00105	CbGpPWpGaD
Cyclobenzaprine—Amitriptyline—DRD2—alcohol dependence	7.99e-05	0.0122	CrCbGaD
Cyclobenzaprine—Doxepin—HTR2A—alcohol dependence	7.98e-05	0.0122	CrCbGaD
Cyclobenzaprine—HTR2A—GPCR ligand binding—DRD2—alcohol dependence	7.88e-05	0.00103	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR ligand binding—HTR7—alcohol dependence	7.88e-05	0.00103	CbGpPWpGaD
Cyclobenzaprine—Imipramine—CYP2E1—alcohol dependence	7.74e-05	0.0118	CrCbGaD
Cyclobenzaprine—Amitriptyline—CYP2E1—alcohol dependence	7.69e-05	0.0117	CrCbGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—PDYN—alcohol dependence	7.68e-05	0.00101	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—OPRD1—alcohol dependence	7.27e-05	0.000953	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Biological oxidations—MAOA—alcohol dependence	7.21e-05	0.000945	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—CRHR1—alcohol dependence	7.14e-05	0.000936	CbGpPWpGaD
Cyclobenzaprine—Promazine—HTR2A—alcohol dependence	7.1e-05	0.0108	CrCbGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—PDYN—alcohol dependence	6.97e-05	0.000914	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	6.82e-05	0.000894	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Biological oxidations—CYP2E1—alcohol dependence	6.77e-05	0.000887	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—CHRM2—alcohol dependence	6.71e-05	0.00088	CbGpPWpGaD
Cyclobenzaprine—HTR2A—SIDS Susceptibility Pathways—EP300—alcohol dependence	6.71e-05	0.000879	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metapathway biotransformation—CYP2E1—alcohol dependence	6.67e-05	0.000874	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR ligand binding—AVP—alcohol dependence	6.64e-05	0.00087	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—CRHR1—alcohol dependence	6.48e-05	0.00085	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—OPRK1—alcohol dependence	6.39e-05	0.000838	CbGpPWpGaD
Cyclobenzaprine—Imipramine—HTR2A—alcohol dependence	6.21e-05	0.00946	CrCbGaD
Cyclobenzaprine—CYP3A4—Biological oxidations—GGT1—alcohol dependence	6.21e-05	0.000814	CbGpPWpGaD
Cyclobenzaprine—Amitriptyline—HTR2A—alcohol dependence	6.17e-05	0.0094	CrCbGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—OPRM1—alcohol dependence	6.16e-05	0.000808	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—CHRM2—alcohol dependence	6.1e-05	0.000799	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—ADH6—alcohol dependence	5.98e-05	0.000784	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Class A/1 (Rhodopsin-like receptors)—POMC—alcohol dependence	5.79e-05	0.000759	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—NPY—alcohol dependence	5.67e-05	0.000743	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—OPRM1—alcohol dependence	5.6e-05	0.000733	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Biological oxidations—MAOA—alcohol dependence	5.57e-05	0.00073	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Biological oxidations—POMC—alcohol dependence	5.54e-05	0.000726	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—HTR1B—alcohol dependence	5.47e-05	0.000717	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—CRH—alcohol dependence	5.47e-05	0.000717	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—NPY—alcohol dependence	5.15e-05	0.000675	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—ADH6—alcohol dependence	5.07e-05	0.000664	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—HTR1B—alcohol dependence	4.97e-05	0.000651	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—CRH—alcohol dependence	4.97e-05	0.000651	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—ADH1A—alcohol dependence	4.96e-05	0.000649	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—DRD4—alcohol dependence	4.78e-05	0.000627	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Biological oxidations—POMC—alcohol dependence	4.7e-05	0.000615	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—CNR1—alcohol dependence	4.57e-05	0.000599	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—HTR7—alcohol dependence	4.46e-05	0.000584	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—DRD2—alcohol dependence	4.46e-05	0.000584	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR ligand binding—POMC—alcohol dependence	4.41e-05	0.000578	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—DRD4—alcohol dependence	4.34e-05	0.000569	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—OPRD1—alcohol dependence	4.3e-05	0.000563	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—ADH4—alcohol dependence	4.21e-05	0.000552	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—ADH1A—alcohol dependence	4.2e-05	0.00055	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—CNR1—alcohol dependence	4.15e-05	0.000544	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—PDYN—alcohol dependence	4.12e-05	0.00054	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—DRD2—alcohol dependence	4.05e-05	0.00053	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—HTR7—alcohol dependence	4.05e-05	0.00053	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—ADH6—alcohol dependence	3.91e-05	0.000512	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—WASF2—alcohol dependence	3.83e-05	0.000502	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—CRHR1—alcohol dependence	3.83e-05	0.000502	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—AVP—alcohol dependence	3.75e-05	0.000492	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—WASF1—alcohol dependence	3.67e-05	0.000481	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Biological oxidations—POMC—alcohol dependence	3.62e-05	0.000475	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—CHRM2—alcohol dependence	3.6e-05	0.000472	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—ADH7—alcohol dependence	3.58e-05	0.00047	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—ADH4—alcohol dependence	3.57e-05	0.000468	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—GGT2—alcohol dependence	3.44e-05	0.00045	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—AVP—alcohol dependence	3.41e-05	0.000446	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—OPRM1—alcohol dependence	3.31e-05	0.000433	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—ADH1A—alcohol dependence	3.24e-05	0.000425	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—ADH1B—alcohol dependence	3.14e-05	0.000412	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism of lipids and lipoproteins—GGT1—alcohol dependence	3.09e-05	0.000405	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—NPY—alcohol dependence	3.04e-05	0.000399	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—ADH7—alcohol dependence	3.04e-05	0.000398	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—CRH—alcohol dependence	2.94e-05	0.000385	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—HTR1B—alcohol dependence	2.94e-05	0.000385	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—GGT2—alcohol dependence	2.91e-05	0.000381	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—ADH4—alcohol dependence	2.75e-05	0.000361	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—ADH1B—alcohol dependence	2.66e-05	0.000349	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—MAOB—alcohol dependence	2.6e-05	0.000341	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—DRD4—alcohol dependence	2.57e-05	0.000336	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—POMC—alcohol dependence	2.49e-05	0.000327	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—CNR1—alcohol dependence	2.45e-05	0.000321	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—DRD2—alcohol dependence	2.39e-05	0.000313	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—HTR7—alcohol dependence	2.39e-05	0.000313	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—ADH7—alcohol dependence	2.34e-05	0.000307	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—POMC—alcohol dependence	2.26e-05	0.000297	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—GGT2—alcohol dependence	2.25e-05	0.000294	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—ALDH2—alcohol dependence	2.21e-05	0.00029	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—MAOB—alcohol dependence	2.21e-05	0.000289	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—ADH1B—alcohol dependence	2.05e-05	0.000269	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—AVP—alcohol dependence	2.01e-05	0.000264	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—GOT2—alcohol dependence	1.88e-05	0.000247	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—ALDH2—alcohol dependence	1.88e-05	0.000246	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—alcohol dependence	1.8e-05	0.000236	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—CYP2E1—alcohol dependence	1.77e-05	0.000232	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—MAOB—alcohol dependence	1.7e-05	0.000223	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—GGT1—alcohol dependence	1.62e-05	0.000213	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—GOT1—alcohol dependence	1.62e-05	0.000213	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—GOT2—alcohol dependence	1.59e-05	0.000209	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—CYP2E1—alcohol dependence	1.5e-05	0.000196	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—MAOA—alcohol dependence	1.46e-05	0.000191	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—ALDH2—alcohol dependence	1.45e-05	0.00019	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—GGT1—alcohol dependence	1.38e-05	0.00018	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—GOT1—alcohol dependence	1.38e-05	0.00018	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—POMC—alcohol dependence	1.34e-05	0.000175	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—MAOA—alcohol dependence	1.23e-05	0.000162	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—GOT2—alcohol dependence	1.23e-05	0.000161	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—alcohol dependence	1.2e-05	0.000157	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—CYP2E1—alcohol dependence	1.16e-05	0.000152	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—GGT1—alcohol dependence	1.06e-05	0.000139	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—GOT1—alcohol dependence	1.06e-05	0.000139	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—MAOA—alcohol dependence	9.52e-06	0.000125	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—POMC—alcohol dependence	9.48e-06	0.000124	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—EP300—alcohol dependence	8.87e-06	0.000116	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—POMC—alcohol dependence	8.03e-06	0.000105	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—EP300—alcohol dependence	6.29e-06	8.24e-05	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—POMC—alcohol dependence	6.2e-06	8.12e-05	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—EP300—alcohol dependence	5.33e-06	6.98e-05	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—EP300—alcohol dependence	4.11e-06	5.39e-05	CbGpPWpGaD
